Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC signs Memorandum of Understanding with Emulate
An Emulate Inc S1-Chip for complex in vitro 3D Culture model.

The partnership will further the development of Organ-on-a-Chip technology.

The Royal Veterinary College (RVC) has announced it has signed a Memorandum of Understanding (MoU) with Emulate, Inc. to support the development and use of Organ-on-a-Chip (OoC) technology.

The collaboration will allow Emulate to provide technical expertise and support, enabling scientists at the RCVS to design and establish Organ-Chip models of veterinary species. It will also help the RVC pioneer the use of animal Organ-Chips in research, making the technology more accessible to other academic and industry groups.

Dr Dirk Werling, Professor of Molecular Immunology at the RVC, said: “OoC, and other 3D tissue explant systems, will provide veterinary scientists with new tools to develop personalised medicine approaches for companion animals and new treatment strategies for farmed animals. 

“More importantly, it will allow us to perform the necessary experiments from the beginning within the target species, ultimately reducing the number of animals needed. Thus, we are fully following the 3Rs.”

An organ chip model is a type of micro-physiological system that enables the continuous culture of living cells within dynamic, biomimetic environments. 

By recreating physiologically relevant 3D microenvironments outside the body, OoCs enable cell-to-cell interactions and tissue-like behaviour on a miniature scale, and improve understanding of initial interactions of pathogens with the host. They therefore offer a promising tool for developing new intervention strategies by testing the right target in the right tissue. 

OoC technology is already used in human disease research, but it is only starting to be applied in veterinary medicine. The hope is that it could help tailor treatments for pets and vaccines for farm animals. 

Dr Stephan Schuell and Dr Asli Akadil from Emulate said of the collaboration: “We are proud to support the Royal Veterinary College as they establish the first veterinary-focused Organ-Chip service offering. Their work will open new avenues for applying OoC technology to animal health and broaden its impact in both veterinary and human medicine.”

Image (C) Emulate Inc/RVC.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.